{"nctId":"NCT01804036","briefTitle":"Two Contrasting Interventions for Sleep Management","startDateStruct":{"date":"2013-03"},"conditions":["Primary Insomnia","Secondary Insomnia"],"count":72,"armGroups":[{"label":"Zolpidem (Ambien) Treatment","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Zolpidem"]},{"label":"Mind-Body Bridging","type":"EXPERIMENTAL","interventionNames":["Behavioral: Mind-Body Bridging"]}],"interventions":[{"name":"Zolpidem","otherNames":["Ambien"]},{"name":"Mind-Body Bridging","otherNames":["Awareness Training"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* primary insomnia\n* secondary insomnia\n* requiring sleep medication (Zolpidem) for a three-week trial.\n* active duty military service member stationed at Fort Carson.\n\nExclusion Criteria:\n\n* secondary insomnia to a likely medical condition, such as sleep apnea, chronic obstructive pulmonary disease, restless leg syndrome, and other sleep disorders, which are not appropriately treatable with sleep medication.\n* treated for sleep problems using sleep medications which include Lunesta, Ambien, Ambien Controlled Release (CR), Seroquel, Trazodone or Remeron\n* major psychopathology (i.e., schizophrenia)\n* severe depression within the past 90 days\n* suicidal ideation within the past 90 days\n* psychiatrically hospitalized within the past 90 days\n* uncontrolled hypertension or diabetes\n* pregnancy\n* previous use of Zolpidem proved to be ineffective or to cause other unwanted side effects\n* actively abusing controlled substances\n* enrolled in another study","healthyVolunteers":false,"sex":"ALL","minimumAge":"17 Years","maximumAge":"40 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Subjective Measures of Sleep Using Medical Outcomes Study -Sleep Scale, From Baseline at 1-week Follow-up","description":"Medical Outcomes Study - sleep scale. A 12-item validated questionnaire evaluating sleep outcomes over the past 7 days. The subscale Sleep Problems Index - II, is reported, range is 0-100. The greater the value the worse the sleep problems. In the present study, the greater the change from baseline the greater the improvement in sleep problems.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.8","spread":null},{"groupId":"OG001","value":"16.1","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Subjective Measures of Sleep Using Medical Outcomes Study -Sleep Scale, From Baseline at 2 Month Follow-up","description":"Medical Outcomes Study - sleep scale. A 12-item validated questionnaire evaluating sleep outcomes over the past 7 days. The subscale Sleep Problems Index - II, is reported, range is 0-100. The greater the value the worse the sleep problems. In the present study, the greater the change from baseline the greater the improvement in sleep problems.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.38","spread":null},{"groupId":"OG001","value":"21.04","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Insomnia Severity Index, From Baseline at 1-week Follow-up","description":"Insomnia Severity Index - A 7-item validated questionnaire evaluating severity of insomnia symptoms over the past 7 days. The total score is reported with a range of 0-28. The greater the value the greater the insomnia severity. In the present study, the greater the change from baseline the greater the improvement in insomnia severity.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":null},{"groupId":"OG001","value":"4.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Insomnia Severity Index, From Baseline at 2 Month Follow-up","description":"Insomnia Severity Index - A 7-item validated questionnaire evaluating severity of insomnia symptoms over the past 7 days. The total score is reported with a range of 0-28. The greater the value the greater the insomnia severity. In the present study, the greater the change from baseline the greater the improvement in insomnia severity.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.34","spread":null},{"groupId":"OG001","value":"6.38","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Total Sleep Time Using a Sleep Diary, From Baseline at 1-week Follow-up","description":"Sleep Diary - 7 days of data collection. Total Sleep Time (TST, in min.): The amount of time asleep, calculated from the time of falling asleep to waking up. Range 0 - 24 hr. The greater the value the more total sleep was obtained.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69.6","spread":null},{"groupId":"OG001","value":"38.3","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Total Sleep Time Using a Sleep Diary, From Baseline at 2 Month Follow-up","description":"Sleep Diary - 7 days of data collection; Total Sleep Time (TST, in min.): The amount of time asleep, calculated from the time of falling asleep to waking up. Range 0 - 24 hr. The greater the value the more total sleep was obtained.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"74.14","spread":null},{"groupId":"OG001","value":"29.9","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Sleep Onset Latency Using a Sleep Diary, From Baseline at 1-week Follow-up","description":"Sleep Diary - 7 days of data collection; Sleep Onset Latency (SOL, in min.): The time to fall asleep, calculated from the time of turning out the light to falling asleep. Range 0 - 24 hr. A negative value reflects an improvement in SOL at the 1-week follow-up.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.9","spread":null},{"groupId":"OG001","value":"-11.1","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Sleep Onset Latency Using a Sleep Diary, From Baseline at 2 Month Follow-up","description":"Sleep Diary - 7 days of data collection; Sleep Onset Latency (SOL, in min.): The time to fall asleep, calculated from the time of turning out the light to falling asleep. Range 0 - 24 hr. A negative value reflects an improvement in SOL at the 2-month follow-up.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.5","spread":null},{"groupId":"OG001","value":"-13.7","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Waking After Sleep Onset Using a Sleep Diary, From Baseline at 1-week Follow-up","description":"Sleep Diary - 7 days of data collection; Waking After Sleep Onset (WASO, in min.): The duration of awakenings throughout the night, calculated after falling asleep to before the last awakening of waking up and not going back to sleep. Range 0 - 24 hr. A negative value reflects improvement in WASO at the 1-week follow-up.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.3","spread":null},{"groupId":"OG001","value":"-4.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Waking After Sleep Onset Using a Sleep Diary, From Baseline at 2 Month Follow-up","description":"Sleep Diary - 7 days of data collection; Waking After Sleep Onset (WASO, in min.): The duration of awakenings throughout the night, calculated after falling asleep to before the last awakening of waking up and not going back to sleep. Range 0 - 24 hr. A negative value reflects improvement in WASO at the 2-month follow-up.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.8","spread":null},{"groupId":"OG001","value":"-4.5","spread":null}]}]}]},{"type":"SECONDARY","title":"PTSD Check List (PCL) - Military (PCL-M)","description":"The PCL-M is a well-validated 17-item self-report measure to assess PTSD severity among military personnel; both male and female, to assess military-related PTSD. Reliability evidence is very good. Items are based on DSM criteria (DSM-IV criteria for this version) and are rated on a 5-point Likert-type scale that allows the derivation of a quantifiable total score.Range is 0-85, the greater the value the worse the PTSD reported symptoms.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.9","spread":null},{"groupId":"OG001","value":"38.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Center for Epidemiologic Studies Depression Scale (CES-D)","description":"The CES-D is one of the most commonly validated screening tests for helping an individual to determine his or her depression quotient. The 20-item test measures depressive feelings and behaviors during the past week. Each item is summed to obtain a CES-D total score ranging from 0 to 60; higher scores indicate more severe depressive symptoms. A total score of 16 or higher was identified in early studies as indicative of individuals with depressive illness.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.5","spread":null},{"groupId":"OG001","value":"24.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Connor-Davidson Resilience Scale (CD-RISC)","description":"One of the few well-validated measures of resilience is the Connor-Davidson Resilience Scale (CD-RISC), comprising 25 items. All items are summed to obtain a CD-RISC total score ranging from 0-100, with greater total scores indicating greater resilience.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.9","spread":null},{"groupId":"OG001","value":"62.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Mindfulness Assessment (Five-facet Mindfulness Questionnaire; FFMQ)","description":"This is a validated questionnaire which tracks how facets of mindfulness may develop over time. It has 39 items and divides into 5 factors representing the various aspects of mindfulness. The range is 0-195. The greater the value the greater an individual's mindfulness level.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"126.9","spread":null},{"groupId":"OG001","value":"120.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":[]}}}